Overview
Cancer Biomarkers, published by IOS Press (The Netherlands), published 509 papers in 2021–2025, and its papers received 3,428 citations in those years. Its h-index is 68 and its two-year mean citedness is 2.62. On the ITS Journal Score it ranks #6,230 of 62,158 ranked journals and #517 of 1,066 in Biochemistry, Genetics and Molecular Biology.
Key figures
Citations count every citation the journal's papers received in these years, including citations to older papers. Two-year mean citedness is OpenAlex's measure of how often recent papers are cited; it is similar in idea to, but not the same as, an impact factor.
Papers and citations by year
| Year | Papers | Citations received | Open-access papers |
|---|---|---|---|
| 2020 | 171 | 2,904 | 171 |
| 2021 | 146 | 1,517 | 146 |
| 2022 | 131 | 1,105 | 111 |
| 2023 | 107 | 422 | 107 |
| 2024 | 63 | 275 | 63 |
| 2025 | 62 | 109 | 61 |
What it publishes
The leading research topics of its papers (OpenAlex topic classification). Select a topic to find other journals that publish on it.
Similar journals
Ranked journals that publish on the same topics.
| Journal | Field | Score | Papers 2021–2025 | Open access |
|---|---|---|---|---|
| Non-coding RNA Research | Biochemistry, Genetics and Molecular Biology | 76.2 | 382 | 100% |
| Bioengineered | Biochemistry, Genetics and Molecular Biology | 73.2 | 2,311 | 100% |
| MicroRNA | Biochemistry, Genetics and Molecular Biology | 58.8 | 174 | 10% |
| Cancer Cell International | Biochemistry, Genetics and Molecular Biology | 83.4 | 2,403 | 100% |
| Molecular Medicine Reports | Biochemistry, Genetics and Molecular Biology | 81.9 | 1,967 | 99% |
| Experimental and Therapeutic Medicine | Biochemistry, Genetics and Molecular Biology | 79.2 | 3,420 | 100% |
| Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics | Biochemistry, Genetics and Molecular Biology | 71.2 | 676 | 99% |
| Non-Coding RNA | Biochemistry, Genetics and Molecular Biology | 72.9 | 383 | 100% |
Compare with similar journals (side by side with the two closest journals above)
Identity and sources
- ISSN-L: 1574-0153
- Print ISSN: 1574-0153
- Electronic ISSN: 1875-8592
- Publisher: IOS Press
- Listed in DOAJ: Not yet checked
- Crossref: ISSN found in Crossref
- OpenAlex: S61994691
- Journal website: www.iospress.nl
Figures come from OpenAlex (papers, citations, h-index, topics), Crossref (ISSN check) and DOAJ (open-access listing and fees). They change as records are corrected, so treat them as a dated snapshot. This page does not state whether the journal is indexed in Scopus, Web of Science or PubMed.
Questions
What is the ITS Journal Score of Cancer Biomarkers?
It is 71.0 out of 100, which places it #6,230 among ranked journals. The score combines citation impact (45%), h-index (35%) and size (20%) from open OpenAlex data.
What is the impact factor of Cancer Biomarkers?
This site does not publish Journal Impact Factors, which belong to Clarivate. As an open alternative, its two-year mean citedness in OpenAlex is 2.62.
Is Cancer Biomarkers open access?
96% of its papers from 2021–2025 are recorded as open access.
Does Cancer Biomarkers charge a publication fee?
No fee is recorded in the open data used here. Check the journal's own website for its current fees.